Your browser doesn't support javascript.
loading
The effect of infliximab dose escalation in inflammatory bowel disease patients with antibodies to infliximab.
Tun, Gloria S Z; Robinson, Kerry; Marshall, Laura; Wright, Alison; Thompson, Laura; Wild, Graeme; Sargur, Ravishankar; Brooks, Alenka J; Hale, Melissa F; Chew, Thean S; Lobo, Alan J.
Afiliação
  • Tun GSZ; Department of Gastroenterology.
  • Robinson K; Department of Gastroenterology.
  • Marshall L; Department of Gastroenterology.
  • Wright A; Department of Gastroenterology.
  • Thompson L; Department of Gastroenterology.
  • Wild G; Department of Immunology, Sheffield Teaching Hospitals NHS Foundation Trust, Sheffield, UK.
  • Sargur R; Department of Immunology, Sheffield Teaching Hospitals NHS Foundation Trust, Sheffield, UK.
  • Brooks AJ; Department of Gastroenterology.
  • Hale MF; Department of Gastroenterology.
  • Chew TS; Department of Gastroenterology.
  • Lobo AJ; Department of Gastroenterology.
Eur J Gastroenterol Hepatol ; 34(3): 295-301, 2022 03 01.
Article em En | MEDLINE | ID: mdl-35100176
Assuntos
Texto completo
Imprimir
XML
PubMed Links
Buscar no Google

Texto completo: 1 Base de dados: MEDLINE Assunto principal: Doenças Inflamatórias Intestinais / Infliximab Limite: Female / Humans / Male Idioma: En Ano de publicação: 2022 Tipo de documento: Article
Texto completo
Imprimir
XML
PubMed Links
Buscar no Google

Texto completo: 1 Base de dados: MEDLINE Assunto principal: Doenças Inflamatórias Intestinais / Infliximab Limite: Female / Humans / Male Idioma: En Ano de publicação: 2022 Tipo de documento: Article